1 |
Ballinger, A. and S. R. Peikin (2002) Orlistat; its current status as an antiobesity drug. Eur. J. Pharmacol. 440, 109-117.
DOI
ScienceOn
|
2 |
Shi, Y. and P. Burn (2004) Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discov. 3, 695-710.
DOI
ScienceOn
|
3 |
Castro, F., M. S. Palma, M. R. Brochetto-Braga, O. Malaspina, J. Lazaretti, M. Baldo, M. Antila, W. Cossermelli (1994). Biochemical propertiesand study of antigenic cross-reactivity between Africanized honey bee and wasp venom. J. Investig. Allergol. Clin. Immunol. 4, 37-41
|
4 |
Embleton, J. K. and C. W. Pouton (1997) Structure and function of gastrointestinal lipases. Advanced Drug Delivery reviews 25, 15-32.
DOI
ScienceOn
|
5 |
Bhutani, K.K (2007) Potential antiobesity and lipid lowering natural products. Nat. Product Commun. 2, 331-348.
|
6 |
Carey, M. C. and D. M. Small (1983). Lipid digestion and absorption. Annu. Rev. Physiol. 45, 651-677.
DOI
ScienceOn
|